Zenflow has created a novel office-based therapy to permanently relieve symptoms of benign prostatic hyperplasia (BPH or enlarged prostate). BPH affects most men at some point in life and causes frequent and urgent urination that has a major quality of life impact. The device is deployed in a 10-minute procedure under local anesthesia that does not cause tissue destruction or loss of sexual function. As a uniquely easy-to-use and cost-effective solution, the device can treat over 20 million patients worldwide every year.


Back to Companies

Nick Damiano
Co-Founder & CEO
Shreya Mehta
Co-Founder & CTO